24:35 Key Insights in Lung Cancer: from the 22nd Annual Perspectives in Thoracic Oncology HMP Education
25:26 Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents HMP Education
22:30 Managing inevitable delays in tissue testing results: When to wait; when to intervene HMP Education
14:45 Potential and progress in targeting less common markers: HER2, BRAF, KRAS, MET, TRK, and RET HMP Education
23:29 Transitioning checkpoint blockade from the second to first line in advanced NSCLC HMP Education
